Related Experiment Videos

Seizures associated with 1% cyclopentolate eyedrops

D A Fitzgerald1, R M Hanson, C West

  • 1Department of Medicine, Children's Hospital, Sydney, Australia.

Insights

A young boy with cerebral palsy experienced seizures, facial flushing, and rapid heart rate after receiving cyclopentolate eye drops. This highlights a rare but serious atropine-like side effect in brain-damaged children.

Area of Science:

  • Ophthalmology
  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Cyclopentolate is a widely used mydriatic agent in pediatric ophthalmology.
  • Cerebral palsy can affect neurological function and drug metabolism.
  • Mydriatic agents can have systemic side effects, particularly in vulnerable populations.

Observation:

  • A 4.5-year-old boy with cerebral palsy developed seizures, facial flushing, and tachycardia post-cyclopentolate eye drop instillation.
  • The patient had no prior history of seizures or epilepsy.
  • The dosage of cyclopentolate was within the standard range for pediatric use.

Findings:

  • The adverse event presented as an uncommon atropine-like systemic side effect.
  • The child's underlying brain damage from cerebral palsy may have predisposed him to this reaction.
  • No epileptic focus was identified in the patient, suggesting a drug-induced phenomenon.

Implications:

  • Clinicians should be aware of the potential for serious systemic side effects of cyclopentolate in children with neurological impairments.
  • Careful patient selection and monitoring are crucial when administering mydriatics to brain-damaged children.
  • This case underscores the importance of considering drug-induced reactions in the differential diagnosis of seizures in pediatric patients.

Related Concept Videos